Navigation Links
Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
Date:1/7/2008

SAN FRANCISCO, Jan. 7 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced an update on the company's HCV pipeline, including promising second-generation polymerase and protease inhibitor compounds for the treatment of hepatitis C. This update will be presented on Tuesday, January 8, at 2:30 p.m. PT at the JP Morgan Healthcare Conference in San Francisco, CA.

Second-Generation Nucleoside Polymerase Inhibitor Program

Idenix's preclinical HCV nucleoside polymerase inhibitor program comprises two novel nucleotide prodrugs, IDX184 and IDX102. This program is based on Idenix's proprietary liver-targeting technology, which delivers high levels of nucleoside triphosphate in the liver, potentially maximizing drug efficacy and limiting systemic side effects.

In preclinical studies using an HCV replicon assay, IDX184 exhibited 10 times greater potency than nucleosides currently in clinical development. In a 7-day preclinical toxicology study of IDX184, no toxicities, including gastrointestinal or hematological, were observed in monkeys at doses greater than or equal to 600 mg/kg/day. In HCV genotype-1 infected chimpanzees, once- daily oral administration of 10 mg/kg of either nucleotide prodrug produced a rapid and potent inhibition of HCV replication with mean viral load reductions ranging from 1.5 log(10) with IDX102 to 2.5-4.0 log(10) with IDX184 after 4 days of dosing. IDX184 has been selected as the company's lead candidate from this program and clinical data are expected in 2008.

Novel Macrocyclic Protease Inhibitor Program

Idenix is e
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
4. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
7. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
8. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
11. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  Net Medical Xpress Solutions, Inc., (OTC QB: ... the company has signed a letter of intent to ... Huntsville, AL . MedTel Solutions is ... and recruitment of telemedicine physicians. Consideration for the acquisition ... which is expected by June 30, 2013. ...
(Date:5/23/2013)... , May 23, 2013  Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...
(Date:5/23/2013)... , May 23, 2013  Omeros Corporation (NASDAQ: ... Investigational New Drug Application (IND) to evaluate OMS824 ... U.S. Food and Drug Administration (FDA). OMS824 selectively ... areas of the brain linked to a wide ... disease and schizophrenia. OMS824 has shown promising results ...
Breaking Medicine Technology:Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Cardinal Health Selects Datameer for Healthcare Data Discovery 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4
... Open enrollment is an opportune time to find the best ... 15 Through the end of the year, thousands of Nebraska ... This is when the state,s 268,000 Medicare beneficiaries get to ... in 2010. , Prescription drug coverage is a critical part ...
... , , NEW YORK, Dec. ... research report is available in its catalogue: , ... the U.S. and its International Trade [Q4 2009 ... just released December edition of Surgical and Medical ...
Cached Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8
(Date:5/23/2013)... (PRWEB) May 23, 2013 Memorial Day ... , Chaplains have been a part of the U.S. ... Day, like those preceding it, these men and women ... the United States of America. As veterans transition ... their migration to the workplace chaplaincy world. , ...
(Date:5/23/2013)... 23, 2013 “Talk. They Hear You.” ... empowers parents to talk to children as young as ... was launched today by the Substance Abuse and Mental ... in conjunction with SAMHSA’s 2013 National Prevention Week—an annual ... around, substance abuse and mental health issues. , SAMHSA’s ...
(Date:5/23/2013)... - Even while being dragged to its destruction ... fires away, sending signals that thwart the development ... reported in an early online publication at ... often encountered by tumors, the epidermal growth factor ... an international team led by scientists at The ...
(Date:5/23/2013)... characterized as "triple negative" carries a poor prognosis, with ... kill the cancer cells the way it,s supposed to. ... cells don,t respond to chemotherapy, and identifies a mechanism ... Dr. Shawn Li, PhD, and his team at Western,s ... protein called Numb functions to promote the death of ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Dr. Katherine ... new charitable organization in Orange County, OCCares , will ... Orange County. The event details are as follows: , ... Academy Auditorium, 13732 Clinton Street, Garden Grove, CA 92843 , ... crossover music by Christian vocalists Charmaine & Jonathan Thulin. ...
Breaking Medicine News(10 mins):Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 3
... 15 Want beautifully clear, acne-free skin, naturally? Skip ... nature with Burt,s Bees(®) Natural Acne Solutions(TM) products. , ... http://multivu.prnewswire.com/mnr/burtsbees/40454/ , (Photo: ... first and only truly natural* acne line clinically ...
... In support of National Latino AIDS Awareness Day, Tibotec ... commitment to raising awareness of HIV/AIDS issues in the ... GRACE (Gender, Race And Clinical Experience) study, the largest ... treated with HIV medications (treatment-experienced) to compare gender differences ...
... to nature , THURSDAY, Oct. 15 (HealthDay News) -- The closer ... For instance, people who live within 1 kilometer of a park ... , The findings put concrete numbers on a concept that ... nice to see that it shows that, that the closer humans ...
... Oxford UK, 15 October 2009 Elsevier, a ... products and services announced today the launch of ... Spatio-temporal Epidemiology ( http://www.elsevier.com/locate/sste ). The first ... be a primary forum for academics and scholars ...
... Researchers at St. Michael,s Hospital have developed the ... more quickly and reliably diagnose acute heart failure (AHF) ... Journal of the American College of Cardiology , ... greater accuracy. "In Canada, more than 100,000 people ...
... The NFL and National Dairy Council (NDC) today launch Fuel ... childhood obesity by giving youth a voice in changing the ... 36 million youth in 60,000 elementary, middle and high schools ... children and teens to take charge of their health and ...
Cached Medicine News:Health News:Video: Introducing Natural Acne Solutions(TM) By Burt's Bees(R) 2Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 2Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 3Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 4Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 5Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 6Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 7Health News:Green Spaces Boost the Body and the Mind 2Health News:Green Spaces Boost the Body and the Mind 3Health News:Elsevier announces launch of Spatial and Spatio-temporal Epidemiology 2Health News:New mathematical model more accurately diagnoses acute heart failure in emergency rooms 2Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 2Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 3Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 4Health News:NFL, National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 5
Natural-looking colors for dark eyes....
Available in 10 beautiful opaque colors....
Natural eye color change for even the darkest of eyes....
An entirely new way to brighten and enhance natural eye color....
Medicine Products: